Cargando…
NF-κB activation enhances cell death by antimitotic drugs in human prostate cancer cells
BACKGROUND: NF-κB is a transcription factor that promotes inhibition of apoptosis and resistance to chemotherapy. It is commonly believed that inhibition of NF-κB activity can increase sensitivity of cancer cells to chemotherapy. However, there is evidence that NF-κB activation can sensitize cells t...
| Autores principales: | , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2908581/ https://www.ncbi.nlm.nih.gov/pubmed/20618955 http://dx.doi.org/10.1186/1476-4598-9-182 |